Last reviewed: June 10, 2026

Last updated: June 10, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 receptor agonist administered as a subcutaneous injection once weekly. Choosing the correct injection site and rotating between locations helps prevent lipohypertrophy (fatty tissue buildup) and ensures consistent medication absorption into your bloodstream.

Best Body Areas for Semaglutide Injections

Semaglutide is designed for subcutaneous injection, meaning it enters the fatty tissue layer beneath your skin rather than muscle. The FDA-approved injection sites include the abdomen, thigh, and upper arm—all areas with sufficient subcutaneous fat for safe needle placement. The abdomen is often preferred because it provides the largest injection area and typically causes less discomfort than other sites.

The upper abdomen, at least 2 inches away from your belly button, offers reliable absorption and comfortable access for self-injection. Many patients find the lower abdomen equally effective. Your thighs provide an alternative site with good subcutaneous tissue depth, while the back of your upper arms works well if you prefer less visibility or have limited abdominal access. Rotating between these three areas reduces tissue damage and maintains consistent medication delivery.

Proper Semaglutide Injection Depth and Angle

Correct injection depth is critical for medication efficacy. Subcutaneous injections should penetrate only into the fatty tissue layer, not into muscle or deeper structures. Most semaglutide pens use a fine 31-gauge needle that requires inserting at a 45 to 90-degree angle to the skin. Pinching the skin gently before injection helps create a thicker subcutaneous layer and reduces the chance of intramuscular placement.

After inserting the needle, hold it steady for 6 to 10 seconds while depressing the plunger completely to ensure the full dose enters the tissue. Withdrawing too quickly or at an angle can cause leakage from the injection site. Allow 10 seconds after injection before removing the needle to minimize backflow. These simple steps ensure your dose is fully delivered and absorbed predictably.

Rotation Strategy to Prevent Injection Site Complications

Injecting in the same spot repeatedly increases the risk of lipohypertrophy—a hardened, thickened area of fat that can develop under the skin. Rotating your injection site each week prevents this complication and maintains healthy tissue integrity. A practical rotation system involves choosing three to four different body areas and alternating between them on a weekly basis.

Within each body area (abdomen, thigh, or arm), further rotate the specific location by at least one finger-width apart from your previous injection. Keeping a simple log or using the markings on your injection pen container helps track which site you used last week. If you notice any lump, redness, or tenderness at a previous site, avoid that area for at least one month to allow the tissue to recover. This disciplined rotation ensures consistent absorption and extends the longevity of your injection sites.

PlexusDx Compounded Semaglutide and Personalized Dosing Guidance

PlexusDx offers compounded semaglutide injections from licensed 503A compounding pharmacies, available nationwide without insurance or membership fees. Your dose may need to go up as your body responds to treatment—but your price won't. PlexusDx pricing remains flat at the committed tier regardless of dose adjustments, removing financial barriers to optimized therapy.

After your first month of treatment, PlexusDx offers the optional Precision Peptide Genetic Test ($99 add-on), which analyzes 14 metabolic pathways and 150+ genetic insights including GLP1R and GIPR variants. Understanding your individual peptide-pathway genetics helps predict your response profile and informs whether semaglutide, tirzepatide, or a dual-compound approach may suit you best. This personalized framework ensures your injection protocol aligns with your genetic predisposition to weight loss and metabolic improvement.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Which semaglutide injection site causes the least pain?

The abdomen, especially the lower abdomen away from nerve-rich areas, typically produces minimal discomfort. Using a 31-gauge needle and pinching the skin before injection reduces pain further. Rotating sites weekly also prevents soreness from repeated needle trauma to the same location.

How often should I rotate my semaglutide injection sites?

Rotate to a new site every single injection (weekly). Within each body area—abdomen, thigh, or upper arm—space injections at least one finger-width apart to prevent lipohypertrophy. Maintaining a rotation log ensures you don't accidentally reuse a site too soon.

Can I inject semaglutide directly into muscle?

No. Semaglutide is formulated for subcutaneous injection only. Intramuscular injection can alter absorption kinetics and may increase side effects. Always use a 45 to 90-degree angle to target the fatty tissue layer beneath your skin, not muscle underneath.

What does lipohypertrophy feel like and how do I prevent it?

Lipohypertrophy presents as a firm, thickened lump or nodule under the skin at a repeated injection site. Prevention relies entirely on rotating sites weekly across three or four body areas. If you develop a lump, avoid that site for at least one month and continue rotating elsewhere.

Does PlexusDx help me understand whether semaglutide is right for my genetics?

Yes. PlexusDx's Precision Peptide Genetic Test analyzes GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways to predict your response to semaglutide versus tirzepatide or dual-compound therapy. This $99 add-on (after your first month) personalizes your injection plan based on your genetic profile, available exclusively from PlexusDx.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves